Bridging the gap between AI and Biology: generating high-fidelity kinetic data at scale to drive next-gen AI drug design | Kisaco Research
  • Learn about novel methods to generate large, bespoke high-resolution datasets in a matter of weeks instead of months.
  • Explore how high-throughput, high-resolution interaction kinetics can fine tune AI models resulting in more efficient workflows and improved therapeutic characteristics
  • Discover how kinetic datasets generated under multiple pH conditions can support the development of pH dependent binders for cancer therapies using AI.
Sponsor(s): 
SPOC Proteomics
Speaker(s): 

Author:

Bharath Takulapalli, PhD

Founder & CEO
SPOC Biosciences

Bharath is inventor of multiple foundational life science technologies at the interface of nanotechnology, systems biology and ML/AI, to extract 100x more information from systems biology than currently possible. He conceived Sensor-integrated Proteome On Chip (SPOC) technology to bridge a big gap in proteomics space, to democratize high-throughput functional protein screening. SPOC is the first and only technology that enables production of 1000s of full-length folded proteins on 1.5 sq-cm biosensor chips, to simultaneously screen for qualitative, quantitative, and kinetic information on protein bindings/interactions in a single assay, at once. Bharath is also the inventor of FENT solid-state nanopore technology for 1000x faster DNA sequencing at 1/10th cost, being developed by iNanoBio Inc. He raised $18M private capital and secured about $8M from DARPA, NIH. Bharath’s vision is to achieve 90% disease preemption, which is to detect and intervene in pre-disease phases, to cure before full disease onset.

Bharath Takulapalli, PhD

Founder & CEO
SPOC Biosciences

Bharath is inventor of multiple foundational life science technologies at the interface of nanotechnology, systems biology and ML/AI, to extract 100x more information from systems biology than currently possible. He conceived Sensor-integrated Proteome On Chip (SPOC) technology to bridge a big gap in proteomics space, to democratize high-throughput functional protein screening. SPOC is the first and only technology that enables production of 1000s of full-length folded proteins on 1.5 sq-cm biosensor chips, to simultaneously screen for qualitative, quantitative, and kinetic information on protein bindings/interactions in a single assay, at once. Bharath is also the inventor of FENT solid-state nanopore technology for 1000x faster DNA sequencing at 1/10th cost, being developed by iNanoBio Inc. He raised $18M private capital and secured about $8M from DARPA, NIH. Bharath’s vision is to achieve 90% disease preemption, which is to detect and intervene in pre-disease phases, to cure before full disease onset.

Time: 
12:15 PM - 12:45 PM
Agenda Track No.: 
Track 2
Session Type: 
General Session (Presentation)